These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 24001226)
1. Drug design for flavivirus proteases: what are we missing? Poulsen A; Kang C; Keller TH Curr Pharm Des; 2014; 20(21):3422-7. PubMed ID: 24001226 [TBL] [Abstract][Full Text] [Related]
2. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication. Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094 [TBL] [Abstract][Full Text] [Related]
3. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors. Cregar-Hernandez L; Jiao GS; Johnson AT; Lehrer AT; Wong TA; Margosiak SA Antivir Chem Chemother; 2011 May; 21(5):209-17. PubMed ID: 21566267 [TBL] [Abstract][Full Text] [Related]
4. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target. Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567 [TBL] [Abstract][Full Text] [Related]
5. Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review. Wahaab A; Mustafa BE; Hameed M; Stevenson NJ; Anwar MN; Liu K; Wei J; Qiu Y; Ma Z Viruses; 2021 Dec; 14(1):. PubMed ID: 35062249 [TBL] [Abstract][Full Text] [Related]
6. Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease. Li Z; Sakamuru S; Huang R; Brecher M; Koetzner CA; Zhang J; Chen H; Qin CF; Zhang QY; Zhou J; Kramer LD; Xia M; Li H Antiviral Res; 2018 Feb; 150():217-225. PubMed ID: 29288700 [TBL] [Abstract][Full Text] [Related]
7. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease. Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384 [TBL] [Abstract][Full Text] [Related]
8. The flavivirus protease as a target for drug discovery. Brecher M; Zhang J; Li H Virol Sin; 2013 Dec; 28(6):326-36. PubMed ID: 24242363 [TBL] [Abstract][Full Text] [Related]
9. Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease. Nall TA; Chappell KJ; Stoermer MJ; Fang NX; Tyndall JD; Young PR; Fairlie DP J Biol Chem; 2004 Nov; 279(47):48535-42. PubMed ID: 15322074 [TBL] [Abstract][Full Text] [Related]
10. Identification of palmatine as an inhibitor of West Nile virus. Jia F; Zou G; Fan J; Yuan Z Arch Virol; 2010 Aug; 155(8):1325-9. PubMed ID: 20496087 [TBL] [Abstract][Full Text] [Related]
11. High-throughput virtual screening lead to discovery of non-peptidic inhibitors of West Nile virus NS3 protease. Huang D Methods Mol Biol; 2012; 819():615-23. PubMed ID: 22183561 [TBL] [Abstract][Full Text] [Related]
12. Phosphonate inhibitors of West Nile virus NS2B/NS3 protease. Skoreński M; Milewska A; Pyrć K; Sieńczyk M; Oleksyszyn J J Enzyme Inhib Med Chem; 2019 Dec; 34(1):8-14. PubMed ID: 30362835 [TBL] [Abstract][Full Text] [Related]
13. The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development. Luo D; Vasudevan SG; Lescar J Antiviral Res; 2015 Jun; 118():148-58. PubMed ID: 25842996 [TBL] [Abstract][Full Text] [Related]
14. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the West Nile virus protease substrate specificity and inhibitors. Mueller NH; Yon C; Ganesh VK; Padmanabhan R Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926 [TBL] [Abstract][Full Text] [Related]
16. Cell-active carbazole derivatives as inhibitors of the zika virus protease. Rassias G; Zogali V; Swarbrick CMD; Ki Chan KW; Chan SA; Gwee CP; Wang S; Kaplanai E; Canko A; Kiousis D; Lescar J; Luo D; Matsoukas MT; Vasudevan SG Eur J Med Chem; 2019 Oct; 180():536-545. PubMed ID: 31344613 [TBL] [Abstract][Full Text] [Related]
17. Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease. Yao Y; Huo T; Lin YL; Nie S; Wu F; Hua Y; Wu J; Kneubehl AR; Vogt MB; Rico-Hesse R; Song Y J Am Chem Soc; 2019 May; 141(17):6832-6836. PubMed ID: 31017399 [TBL] [Abstract][Full Text] [Related]
18. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors. Lai H; Teramoto T; Padmanabhan R Methods Mol Biol; 2014; 1138():345-60. PubMed ID: 24696347 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 2-{6-[2-(5-phenyl-4H-{1,2,4]triazol-3-ylsulfanyl)acetylamino]benzothiazol-2-ylsulfanyl}acetamide scaffold. Samanta S; Lim TL; Lam Y ChemMedChem; 2013 Jun; 8(6):994-1001. PubMed ID: 23619931 [TBL] [Abstract][Full Text] [Related]
20. Identification and biochemical characterization of small-molecule inhibitors of west nile virus serine protease by a high-throughput screen. Mueller NH; Pattabiraman N; Ansarah-Sobrinho C; Viswanathan P; Pierson TC; Padmanabhan R Antimicrob Agents Chemother; 2008 Sep; 52(9):3385-93. PubMed ID: 18606844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]